It addresses the fragmented international patient journey to Korean healthcare — language barriers, limited provider visibility, manual coordination, and weak follow-up — while giving providers a unified way to reach and manage international patients instead of relying on costly agency intermediaries.
Yes, the core platform is live at doctorsinkorea.com, including doctor/clinic discovery, an AI navigation assistant, a clinic CRM, and a supplier/procurement portal. Some capabilities described in this investor section — including deeper medical tourism agency tooling, video consultation at scale, and enterprise integrations — are in active development.
Early commercial stage: the platform is live, provider onboarding and lead-management workflows are functional, and the company is validating pricing and go-to-market approach ahead of a broader launch.
Primarily recurring clinic/hospital subscriptions, plus premium listings, AI usage fees, patient referral and coordination fees (where legally permitted), advertising/sponsorship, and API/white-label services. See the Financials page for detail.
On the provider side: clinics, hospitals, and specialists seeking international patients. On the patient side: international patients researching or seeking treatment in Korea. On the partner side: medical tourism agencies, insurers, travel/concierge companies, and technology providers.
A proposed pre-seed / strategic investment round with a target of US$500,000, with a flexible range of US$350,000–US$750,000. Exact terms are subject to investor discussions and due diligence.
Primarily product/technology development, sales and provider acquisition, international patient marketing, AI/cloud/communication infrastructure, compliance and security, operations, and a contingency reserve. See the proposed allocation on the Financials page.
Healthcare advertising restrictions, telemedicine regulation, cross-border patient data handling, and provider verification requirements are the primary regulatory considerations, reviewed on a per-market basis. See the Risks & Mitigation section for detail.
Every provider record carries a verification-status field, and providers go through admin review before activation on the platform.
The AI is explicitly scoped to administrative navigation — routing a patient's described symptoms toward a specialty and urgency level — not diagnosis. This is stated as a disclaimer wherever the AI assistant is used, and the platform is designed so that clinical decisions remain with licensed healthcare professionals.
A mix of multilingual SEO and content, paid search, social media, medical tourism agency and travel partnerships, embassy/community partnerships, and country-specific landing pages. See the Go-to-Market section on the Financials page.
A directory stops at discovery. DoctorsInKorea.com is designed to support the full patient journey — AI-assisted navigation, multilingual communication, appointment/video consultation requests, medical tourism coordination, and post-treatment follow-up — alongside a CRM and analytics layer for providers.
Korea-first, with the medium-term roadmap including expansion into GCC patient demand, Southeast Asia, Central Asia, Europe, and North America as patient-acquisition and provider-supply channels. See the Five-Year Roadmap on the Financials page.
Structure (equity, SAFE, convertible note, or strategic partnership) is discussed directly with qualified investors. Valuation and equity terms are not published publicly and are shared under NDA.
Through the partnership models described on the Partnerships page — as a provider, medical tourism agency, insurance partner, travel/concierge partner, technology partner, government program, or research collaborator.
Submit an inquiry through the form on the Investors page indicating your interest, or select "NDA required" if you'd like to review detailed financials before a call.
No. All financial figures presented are targets, projections, estimates, or management assumptions, not guaranteed outcomes. Investing involves risk, including the risk of total loss.
A more detailed financial model with scenario planning, the current cap table structure, and additional operational detail can be shared with qualified investors under NDA.
Investment information on this page is provided for discussion purposes only and does not constitute an offer, solicitation, or financial guarantee. Figures marked Target, Projection, Estimate, or Management Assumption are illustrative and not guaranteed outcomes. Investments involve risk, including the risk of total loss; past or projected performance is not indicative of future results.